Updates

Research Research News

Latest Research News

Research Jul. 14, 2022

Insights into cause of Gaucher disease discovered

Research Jun. 27, 2022

Joo Hyun Kim receives a prestigious fellowship from the American Epilepsy Society

Research Jun. 20, 2022

Dr. Zoghbi receives International Prize for Translational Neuroscience

Research Jun. 07, 2022

Dr. Kara Marshall named a McNair Scholar by the McNair Medical Institute

Research Jun. 06, 2022

A faster, less expensive approach identifies highly specific anti-cancer compounds

Research Jun. 01, 2022

Dr. Huda Zoghbi named the 2022 Kavli Prize Laureate in neuroscience

Research May. 25, 2022

Cross-disciplinary Alzheimer's Disease Research Symposium

Research May. 16, 2022

Finding the right diagnosis for one child can help millions more

Research May. 11, 2022

A pioneering study discovers an underlying cause for infantile spasms and points to a novel therapy

Research May. 11, 2022

Uncovering a novel therapy for infantile spasms

Research Abr. 03, 2022

NCI-COG Pediatric MATCH study shows benefit of genetic screening in refractory tumors

Research Mar. 14, 2022

Reduced inhibition of hippocampal neurons impairs long-term memory recall in Rett syndrome

Research Oct. 20, 2021

Texas Children’s Researchers Discover A Noninvasive Method To Locate Seizure Foci In Infantile Spasms

Research Jun. 18, 2021

Iacobas to serve on vascular anomalies committee

Research May. 20, 2021

Fluorescent dye helps guide pediatric liver tumor resection

Research May. 05, 2021

Alemtuzumab as part of conditioning therapy for Graft-Vs-Host Disease in children and young adults

Research Abr. 26, 2021

Biological E Ltd gets approval to start Phase III clinical trial of its COVID vaccine candidate developed at Texas Children's Hospital's Center for Vaccine Development

Research Abr. 20, 2021

POT1 gene mutation predisposes to glioma and affects survival in a sex-specific manner

Research Mar. 24, 2021

Study reveals how long-term infection and inflammation impairs immune response as we age

Research Mar. 04, 2021

Proteomics analysis identifies potential drug targets for aggressive human cancers